- 收听数
- 0
- 性别
- 女
- 听众数
- 15
- 最后登录
- 2024-1-30
- QQ
 - UID
- 5276
- 阅读权限
- 10
- 帖子
- 159
- 精华
- 0
- 在线时间
- 102 小时
- 注册时间
- 2013-8-3
- 科研币
- 0
- 速递币
- 1273
- 娱乐币
- 2664
- 文献值
- 8
- 资源值
- 0
- 贡献值
- 0
|
5速递币
| 题名 | afety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial | | 链接 | 今日求助第一篇文章的supplement.部分内容。safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trialhttps://www.sciencedirect.com/science/article/pii/S0140673618311152 谢谢 |
求助supplement部分内容 谢谢 |
|
发表于 2019-11-26 09:22:59
淘帖
收藏
顶
踩
发表于 2019-11-26 09:23:00
